Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy

By performing regular blood transfusion and iron chelation therapy, most patients with beta thalassemia major (BTM) now survive beyond the third decade of life. Liver disease is becoming an important cause of morbidity and mortality in these patients. Chronic hepatitis and/or severe iron overload ar...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Soliman, Ashraf, Yassin, Mohamed, Al Yafei, Fawzia, Al-Naimi, Lolwa, Almarri, Noora, Sabt, Aml, De Sanctis, Vincenzo
Format: Artigo
Langue:Inglês
Publié: Università Cattolica del Sacro Cuore 2014
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010606/
https://ncbi.nlm.nih.gov/pubmed/24803998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2014.025
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires